pravastatin has been researched along with malondialdehyde in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviram, M; Brook, GJ; Hoffman, R | 1 |
| Birkenhäger, JC; Ghanem, H; Jansen, H; Kuypers, JH | 1 |
| Chen, MF; Hsu, HC; Lee, YT | 1 |
| de Almeida, E; Jorge, PA; Osaki, MR | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T | 1 |
| Nasu, M; Tamura, A; Watanabe, T | 1 |
| Andreadou, I; Aznaouridis, K; Cimponeriu, A; Karatzis, E; Lekakis, J; Mavrikakis, M; Papaioannou, TG; Papamichael, C; Protogerou, A | 1 |
| Almeida, EA; Carneiro, A; Jorge, M; Jorge, PA; Ozaki, MR | 1 |
| Anazawa, T; Furukawa, K; Kanmatsuse, K; Kawamata, H; Kushiro, T; Nagao, K; Sato, Y; Tachibana, E; Tani, S; Watanabe, I | 1 |
| Kametsu, Y; Kitagawa, Y; Sekiyama, S; Takagi, S | 1 |
| Kastelein, JJ; Miller, ER; Ridker, PM; Rodenburg, J; Tsimikas, S; Vissers, MN; Wiegman, A; Witztum, JL | 1 |
| Chen, C; Ran, ZH; Xiao, SD | 1 |
| Chae, A; Choi, SH; DeMaria, AN; Messig, M; Miller, E; Nissen, SE; Ntanios, F; Tsimikas, S; Witztum, JL | 1 |
| Anazawa, T; Fuji, T; Furuya, S; Hirayama, A; Iida, K; Kawamata, H; Kumabe, T; Matsumoto, M; Nagao, K; Sato, Y; Takahashi, H; Tani, S | 1 |
| Fujieda, M; Hayashi, Y; Ishihara, M; Morita, T; Naruse, K; Ohta, K; Toma, T; Wakiguchi, H; Yokoyama, T | 1 |
| Abdallah, GM; Alanazi, FK; El-Bassat, RA; Harisa, GI; Malik, A | 1 |
5 trial(s) available for pravastatin and malondialdehyde
| Article | Year |
|---|---|
Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B.
Topics: Autoantibodies; Coronary Disease; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pravastatin | 1995 |
Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, HDL; Cross-Over Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Pravastatin; Pyrroles | 2003 |
Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina.
Topics: Aged; Angina, Unstable; Brachial Artery; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nuclear Proteins; Oxidative Stress; Placebos; Pravastatin | 2005 |
Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound.
Topics: Anticholesteremic Agents; Cholesterol; Coronary Disease; Diabetes Mellitus; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pravastatin; Risk Factors; Smoking; Ultrasonography | 2005 |
Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
Topics: Anticholesteremic Agents; Antigen-Antibody Complex; Apolipoproteins B; Autoantibodies; Child; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Male; Malondialdehyde; Pravastatin; Siblings | 2006 |
11 other study(ies) available for pravastatin and malondialdehyde
| Article | Year |
|---|---|
Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.
Topics: Adult; Animals; Bezafibrate; Cells, Cultured; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Esterification; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Malondialdehyde; Mice; Middle Aged; Pravastatin; Vitamin E | 1992 |
Effects of acute exercise on the changes of lipid profiles and peroxides, prostanoids, and platelet activation in hypercholesterolemic patients before and after treatment.
Topics: beta-Thromboglobulin; Exercise; Female; Humans; Hypercholesterolemia; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Peroxides; Platelet Activation; Pravastatin; Prostaglandins; Thromboxanes | 1994 |
Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin.
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Cholesterol; Endothelium, Vascular; Hypercholesterolemia; Male; Malondialdehyde; Muscle Relaxation; Pravastatin; Rabbits; Simvastatin | 1997 |
Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
Topics: Acetylcholine; Animals; Anti-Bacterial Agents; Anticholesteremic Agents; Aorta; Blood Glucose; Cholesterol; Diabetes Mellitus; Drug Interactions; Endothelium, Vascular; Lipoproteins, LDL; Male; Malondialdehyde; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Oxidation-Reduction; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Triglycerides; Vasodilation | 2000 |
[Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
Topics: Animals; Anticholesteremic Agents; Aortic Diseases; Arteriosclerosis; Atorvastatin; Cholesterol; Cholesterol, LDL; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Hypercholesterolemia; Indoles; Lipid Peroxidation; Male; Malondialdehyde; Pravastatin; Pyrroles; Rabbits; Simvastatin | 2005 |
Increase in plasma malondialdehyde-modified low-density lipoprotein in patients with atherothrombotic cerebral infarction.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Carotid Arteries; Cerebral Infarction; Cholesterol, LDL; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pravastatin; Statistics as Topic; Ultrasonography, Doppler | 2005 |
[Therapeutic effects of pravastatin on colitis induced by acetic acid and relevant mechanism: experiment with rats].
Topics: Acetic Acid; Animals; Colitis, Ulcerative; Colon; Disease Models, Animal; Male; Malondialdehyde; Nitric Oxide; Pravastatin; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2006 |
Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins B; Atherosclerosis; Atorvastatin; Autoantibodies; Biomarkers; Cholesterol, LDL; Coronary Angiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunoglobulin M; Lipoprotein(a); Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phospholipids; Pravastatin; Prospective Studies; Pyrroles; Research Design | 2008 |
Treatment of coronary spastic angina with a statin in addition to a calcium channel blocker: a pilot study.
Topics: Angina Pectoris, Variant; Calcium Channel Blockers; Cholesterol, HDL; Cholesterol, LDL; Coronary Vasospasm; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pilot Projects; Pravastatin | 2008 |
Effect of pravastatin on cisplatin-induced nephrotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cisplatin; Gene Expression Regulation, Enzymologic; Glutathione; Glutathione Peroxidase; Kidney; Kidney Diseases; Kidney Function Tests; Male; Malondialdehyde; Pravastatin; Rats; Rats, Wistar; Tumor Suppressor Protein p53; Up-Regulation | 2011 |
Protective effect of pravastatin against mercury induced vascular cells damage: erythrocytes as surrogate markers.
Topics: Adult; Antioxidants; Catalase; Cells, Cultured; Environmental Pollutants; Erythrocytes; Glutathione Peroxidase; Hematocrit; Hemoglobins; Hemolysis; Humans; Malondialdehyde; Mercury; Nitrites; Pravastatin; Protein Carbonylation; Superoxide Dismutase | 2012 |